La Malattia Cardiovascolare in Europa
Transcript
La Malattia Cardiovascolare in Europa
La Malattia Cardiovascolare in Europa (CVD) 1 E’ la l principale i i l causa di morte t contando t d per il 41% % di tutti i decessi (Eurostat 2003) 1.2 milioni di decessi in Europa p / anno 1/3 degli anni di vita perduti per morte precoce secondaria a CVD www.cardiovascularprevention.com Maggiori cause di morte in EU anno 2003 per gruppi di 5 anni di età www.cardiovascularprevention.com 2 Age-standardised death rates, per 100.000, from CHD 1968-2002, CHD, 68 selected l d countries, i the h world ld ((1)) From: Steven Allender, Viv Peto, Peter Scarborough, Asha Kaur and Mike Rayner (2008) Coronary heart disease statistics. British Heart Foundation: London. www.cardiovascularprevention.com 3 3 Age-standardised death rates, per 100.000, from CHD 1968-2002, CHD, 68 selected l d countries, i the h world ld ((2)) From: Steven Allender, Viv Peto, Peter Scarborough, Asha Kaur and Mike Rayner (2008) Coronary heart disease statistics. British Heart Foundation: London. www.cardiovascularprevention.com 4 4 EUROPE 1995-2006 www.cardiovascularprevention.com 5 5 Cardiovascular Disease in United Kingdom -20062006 6 Diseases of the heart and circulatoryy system y ((cardiovascular disease or CVD)) are the main cause of death in the UK and account for almost 198,000 deaths each year. More than one in three deaths (35%) are from CVD each year. The main forms of CVD are coronary heart disease (CHD: Acute myocardial infarction, Angina pectoris, sudden cardiac death) and stroke. About half (48%) of all deaths from CVD are from CHD and more than a quarter (28%) are from stroke. CHD by itself is the most common cause of death in the UK. UK Around one in five men and one in seven women die from the disease. CHD causes around 94,000 deaths in the UK each year. Other forms of heart disease cause over 31,000 deaths in the UK each year so in total there were just under 126,000 deaths from heart disease in the UK in 2006. Premature mortality(death before the age of 75). CVD is one of the main causes of premature death in the UK 30% of premature deaths in men and 22% of premature deaths in women were from CVD in 2006. CVD caused just over 53,000 premature deaths in the UK in 2006. CHD, by itself, is the most common cause of premature death in the UK About one fifth (19%) of premature deaths in men and one in ten (10%) premature deaths in women were from CHD. CHD caused almost 31,000 premature deaths in the UK in 2006. Other forms of heart disease cause more than 7,500 premature deaths in the UK each year. In total there were over 38,000 premature deaths from heart disease in the UK in 2006 - around one fifth of all premature deaths. From: Steven Allender, Viv Peto, Peter Scarborough, Asha Kaur and Mike Rayner (2008) Coronary heart disease statistics. British Heart Foundation: London. www.cardiovascularprevention.com 6 DEATHS BY SEX, AGE, UNITED KINGDOM 20067 From: Steven Allender, Viv Peto, Peter Scarborough, Asha Kaur and Mike Rayner (2008) Coronary heart disease statistics. British Heart Foundation: London. www.cardiovascularprevention.com 7 Incidenza in Italia p per anno 8 Sindromi coronariche acute 280.000 280 000 M 78.000 F + 50.000 morti improvvise Solo S l il 30% % dei d i soggetti tti con fattori f tt i di rischio i hi tradizionali manifesta segni di CAD Studio: Pz giovani, 50 aa. senza FRC: nel 50% %M M, 25% % F , IMA o Morte M t come prima i manifestazione di CAD, di questi Il 68% ha h stenosi t i coronariche i h subcritiche, b iti h < 50% www.cardiovascularprevention.com Mortalità Per Grandi Gruppi anno 2002 9 - ISTAT (Italy) Malattie Cardiovascolari Tumori 237.198 163.070 Morte improvvisa 54 000 54.000 www.cardiovascularprevention.com Numero dimessi 2004 - Ricoveri per acuti. ti (ISTAT – Italy) 10 Tumori 7 5 761.582 Malattie cardiovascolari 1.413.082 www.cardiovascularprevention.com CONSUMO DI FARMACI Consumo nazionale di farmaci a carico del Servizio Sanitario Nazionale per categorie terapeutiche (ATC al I° livello) - Anno 2005 CATEGORIA TERAPEUTICA DDD ogni 1.000 abitanti al giorno CARDIOVASCOLARE GASTROINTESTINALE E METABOLISMO ANTIMICROBICI SISTEMA NERVOSO CENTRALE RESPIRATORIO ANTINEOPLASTICI EMATOLOGICI GENITO-URINARI E ORMONI SESSUALI MUSCOLO-SCHELETRICO ORMONI SISTEMICI ORGANI DI SENSO DERMATOLOGICI VARI ANTIPARASSITARI 392,2 92,9 24,2 46,3 48 0 48,0 5,7 72,3 40,2 37,9 27,7 15,7 3,0 0,2 06 0,6 806,9 DDD - Daily Defined Dose (dose giornaliera di mantenimento in un adulto) Fonte: AIFA - Rapporto nazionale OSMED sul consumo di farmaci 2005 ITALY www.cardiovascularprevention.com 11 Variazione percentuale rispetto al 2004 % 48,6 11,5 3,0 5,7 59 5,9 0,7 9,0 5,0 4,7 3,4 1,9 0,4 0,0 01 0,1 100,0 4,7 5,3 4,8 7,1 54 5,4 -3,0 6,6 -1,8 -7,9 7,9 0,8 -1,5 -2,0 35 3,5 4,0 Particolari condizioni associate ad elevata l t mortalità t lità cardiovascolare di l 12 Diabete mellito Scompenso cardiaco Ictus ischemico/emorragico / g www.cardiovascularprevention.com U.S.A. Data 1999-2002 999 13 Of the 71 300 000 American adults with 1 or more types of • cardiovascular disease (CVD), 27 400 000 g 65 5 or older are estimated to be age High blood pressure 65 000 000. Coronaryy heart disease 13 200 000. – Myocardial infarction (MI, or heart attack) 7 200 000. – Angina pectoris (AP, or chest pain) 6 500 000. Heart failure 5 000 000. Stroke 5 500 000. Congenital cardiovascular defects 1 000 000. www.cardiovascularprevention.com USA Death rate in 2003 • Th The 2003 preliminary li i CVD d death th rates t were 364.2 364 2 for f males l and 262.5 for females. • Cancer death rates were 232.3 for males and 160.2 for f females. l • Breast cancer claimed the lives of 41 566 females in 2003. • Lung g cancer claimed 67 894. • Death rates for females were 25.2 for breast cancer and 41.1 for lung cancer. • One in 30 female deaths are from breast cancer, cancer while 1 in 2.6 are from CVD. • Based on preliminary 2003 mortality, CVD caused about a death a minute among females over • 480 000 female lives every year. www.cardiovascularprevention.com 14 U.S.A. Data 2003 & cost 2006 www.cardiovascularprevention.com 15 Other causes of death in 2003 in USA (preliminary data) • • • • Cancer 554 643 Accidents 105 695 Alzheimer’s disease 63 343 HIV (AIDS) 13 544 544. www.cardiovascularprevention.com 16 CARDIOVASCULAR DISEASE IN CANADA (2) These statistics are based on 2004 data (from Statistics Canada) Cardiac arrest Aboutt 40,000 Ab 40 000 Canadians C di experience i cardiac di arrestt every year. Less than 5% of those who have a cardiac arrest outside of a hospital survive. Congestive heart failure It is estimated that there are 400,000 400 000 Canadians living with congestive heart failure (CHF). Stroke More than 50,000 strokes occur in Canada each year. That’s one stroke everyy 10 minutes. Stroke is the third leading cause of death in Canada. Each year, more than 14,000 Canadians die from stroke. Each yyear, more women than men die from stroke. www.cardiovascularprevention.com 17 ACUTE CORONARY SINDROME IN INDIA 18 India has the largest percentage of heart disease in the world Xavier X i ett al's, l' examined i d th the iincidence id off STEMI and d non-STEMI STEMI among almost 21 000 patients from 89 centers in 50 Indian cities. They found that more than 60% of these patients were diagnosed with STEMI, mean age was 57.5 years (although STEMI patients tended to be even younger), and the vast majority j i were ffrom llower-middle-income iddl i or poor ffamilies. ili The Indians were, on average, 57,5 years of age compared with 70.7 years for the European whites. whites Reinfarction, and stroke rates and 30-day death, were higher for STEMI patients than non-STEMI, and mortality, notably, was significantly higher in poor patients than in rich patients. They also had significantly increased prevalence of diabetes, hypertension, history of CAD compared with European whites. And triple-vessel disease was more common in the Indian Asians than in the whites. whites Almost all STEMI and non-STEMI patients were treated with antiplatelet drugs (primarily aspirin), but use of thrombolytics, ACE inhibitors or Angiotensin-Receptor Blockers, beta blockers, statins, omega 3 fatty-acids and d PCI/CABG were all ll far f lower l than th rates t seen in i the th West. W t www.cardiovascularprevention.com 18 India: Mortality rates and socioeconomic status 19 M t lit Mortality Rich Ri h (%) Unadjusted mortality 5.5 Mortality adjusted for 7.2 risk i k ffactors, t location l ti of infarct, and treatments Lower Poor L P (%) p middle class (%) 6.5 6.4 8.2 6.6 From: Xavier D. et al. Lancet 2008; 371:1435-1442. www.cardiovascularprevention.com 19 <0.0001 0.97 Ten-year risk of CVD event (%) in 60-yearolds ld British i i h minority i i Ethnic h i groups 20 Ethnic group Male nonsmoker Male smoker Female nonsmoker Female smoker Indian 22.4 36.7 8.7 15.1 Pakistani 24.7 40.0 13.4 22.8 Bangladeshi 24.9 40.4 7.4 13.0 All South Asians Chinese 23.6 38.5 9.7 16.9 11 1 11.1 19 1 19.1 25 2.5 44 4.4 Caribbean 13.3 22.7 9.7 16.9 Black African 20 1 20.1 33 3 33.3 10 8 10.8 18 7 18.7 Irish 16.0 27.0 9.1 15.8 g Framingham score 14.1 22.3 8.7 14.7 From: P Brindle, M May, et Al: Heart 2006;92:1595–1602. doi: 10.1136/hrt.2006.092346 20 www.cardiovascularprevention.com Health care costs off CVD,, CHD and stroke by EU country, 2006, Europe CVD Cost per capita Country (€) Austria 198 Belgium Bulgaria Cyprus CHD % of total health expenditure Cost per Stroke % of total capita (€) health expenditure Cost per % of total capita health (€) expenditure 1 6 43 1 35 193 6 46 1 27 1 Ì5 14 6 2 7 3 59 5 18 2 7 l Czech Republic 107 13 25 3 16 2 Denmark 182 5 44 1 37 l Estonia 77 15 22 4 14 3 Finland 237 10 52 2 65 3 France 207 7 32 ! 2; 1 Germany 413 14 96 3 58 1 Greece 173 10 46 3 44 2 75 111 15 2 10 1 Hungary Ireland 183 6 46 1 26 1 Italy 235 in 45 2 45 2 L t i Latvia 47 9 13 3 8 2 Lithuania 59 13 14 3 14 3 252 5 60 1 24 0 72 6 IS 1 5 0 Luxembourg Malta Netherlands 271 9 73 2 78 3 74 17 18 4 10 2 Portugal 151 LO 33 2 27 2 Romania 14 15 6 3 6 2 Slovakia 74 13 21 4 11 2 Slovenia 91 7 19 1 12 1 Spain 130 7 31 2 Sweden 308 10 62 2 52 UK 313 12 71 3 69 Total EU 223 10 49 2 38 Poland 17 From: Steven Allender, Viv Peto, Peter Scarborough, Asha Kaur and Mike Rayner (2008) Coronary heart disease statistics. British Heart Foundation: London. 1 2 3 2 21 www.cardiovascularprevention.com Problemi cardiologici g attuali e futuri • Sproporzione tra la domanda crescente di prestazioni e le risorse economiche scarse p • Ciò richiede i hi d ffondamentali d t li modifiche difi h nella ll strategia diagnostica e terapeutica www.cardiovascularprevention.com 22 Circulation January 24, 2006 Alter et al The Proliferation of Cardiac Technology In Canada www.cardiovascularprevention.com 23 Lucas et al Temporal Trends in Cardiac Testing and Treatment- USA- Circulation January 24, 2006 www.cardiovascularprevention.com 24 www CardioVascularPrevention com www.CardioVascularPrevention.com E-mail: [email protected] 25